Improving Co-Amorphous Drug Formulations by the Addition of the Highly Water Soluble Amino Acid, Proline

Co-amorphous drug amino acid mixtures were previously shown to be a promising approach to create physically stable amorphous systems with the improved dissolution properties of poorly water-soluble drugs. The aim of this work was to expand the co-amorphous drug amino acid mixture approach by combin...

Full description

Bibliographic Details
Main Authors: Katrine Tarp Jensen, Korbinian Löbmann, Thomas Rades, Holger Grohganz
Format: Article
Language:English
Published: MDPI AG 2014-07-01
Series:Pharmaceutics
Subjects:
Online Access:http://www.mdpi.com/1999-4923/6/3/416
_version_ 1798003457090650112
author Katrine Tarp Jensen
Korbinian Löbmann
Thomas Rades
Holger Grohganz
author_facet Katrine Tarp Jensen
Korbinian Löbmann
Thomas Rades
Holger Grohganz
author_sort Katrine Tarp Jensen
collection DOAJ
description Co-amorphous drug amino acid mixtures were previously shown to be a promising approach to create physically stable amorphous systems with the improved dissolution properties of poorly water-soluble drugs. The aim of this work was to expand the co-amorphous drug amino acid mixture approach by combining the model drug, naproxen (NAP), with an amino acid to physically stabilize the co-amorphous system (tryptophan, TRP, or arginine, ARG) and a second highly soluble amino acid (proline, PRO) for an additional improvement of the dissolution rate. Co-amorphous drug-amino acid blends were prepared by ball milling and investigated for solid state characteristics, stability and the dissolution rate enhancement of NAP. All co-amorphous mixtures were stable at room temperature and 40 °C for a minimum of 84 days. PRO acted as a stabilizer for the co-amorphous system, including NAP–TRP, through enhancing the molecular interactions in the form of hydrogen bonds between all three components in the mixture. A salt formation between the acidic drug, NAP, and the basic amino acid, ARG, was found in co-amorphous NAP–ARG. In comparison to crystalline NAP, binary NAP–TRP and NAP–ARG, it could be shown that the highly soluble amino acid, PRO, improved the dissolution rate of NAP from the ternary co-amorphous systems in combination with either TRP or ARG. In conclusion, both the solubility of the amino acid and potential interactions between the molecules are critical parameters to consider in the development of co-amorphous formulations.
first_indexed 2024-04-11T12:07:55Z
format Article
id doaj.art-efa3507a27ae4950b2edc2c60fe15a10
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-04-11T12:07:55Z
publishDate 2014-07-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-efa3507a27ae4950b2edc2c60fe15a102022-12-22T04:24:40ZengMDPI AGPharmaceutics1999-49232014-07-016341643510.3390/pharmaceutics6030416pharmaceutics6030416Improving Co-Amorphous Drug Formulations by the Addition of the Highly Water Soluble Amino Acid, ProlineKatrine Tarp Jensen0Korbinian Löbmann1Thomas Rades2Holger Grohganz3Department of Pharmacy, University of Copenhagen, Copenhagen 2100, DenmarkDepartment of Pharmacy, University of Copenhagen, Copenhagen 2100, DenmarkDepartment of Pharmacy, University of Copenhagen, Copenhagen 2100, DenmarkDepartment of Pharmacy, University of Copenhagen, Copenhagen 2100, DenmarkCo-amorphous drug amino acid mixtures were previously shown to be a promising approach to create physically stable amorphous systems with the improved dissolution properties of poorly water-soluble drugs. The aim of this work was to expand the co-amorphous drug amino acid mixture approach by combining the model drug, naproxen (NAP), with an amino acid to physically stabilize the co-amorphous system (tryptophan, TRP, or arginine, ARG) and a second highly soluble amino acid (proline, PRO) for an additional improvement of the dissolution rate. Co-amorphous drug-amino acid blends were prepared by ball milling and investigated for solid state characteristics, stability and the dissolution rate enhancement of NAP. All co-amorphous mixtures were stable at room temperature and 40 °C for a minimum of 84 days. PRO acted as a stabilizer for the co-amorphous system, including NAP–TRP, through enhancing the molecular interactions in the form of hydrogen bonds between all three components in the mixture. A salt formation between the acidic drug, NAP, and the basic amino acid, ARG, was found in co-amorphous NAP–ARG. In comparison to crystalline NAP, binary NAP–TRP and NAP–ARG, it could be shown that the highly soluble amino acid, PRO, improved the dissolution rate of NAP from the ternary co-amorphous systems in combination with either TRP or ARG. In conclusion, both the solubility of the amino acid and potential interactions between the molecules are critical parameters to consider in the development of co-amorphous formulations.http://www.mdpi.com/1999-4923/6/3/416amino acidco-amorphousdissolution rateDSCFTIRsalt formationsolid state analysisstabilityXRPD
spellingShingle Katrine Tarp Jensen
Korbinian Löbmann
Thomas Rades
Holger Grohganz
Improving Co-Amorphous Drug Formulations by the Addition of the Highly Water Soluble Amino Acid, Proline
Pharmaceutics
amino acid
co-amorphous
dissolution rate
DSC
FTIR
salt formation
solid state analysis
stability
XRPD
title Improving Co-Amorphous Drug Formulations by the Addition of the Highly Water Soluble Amino Acid, Proline
title_full Improving Co-Amorphous Drug Formulations by the Addition of the Highly Water Soluble Amino Acid, Proline
title_fullStr Improving Co-Amorphous Drug Formulations by the Addition of the Highly Water Soluble Amino Acid, Proline
title_full_unstemmed Improving Co-Amorphous Drug Formulations by the Addition of the Highly Water Soluble Amino Acid, Proline
title_short Improving Co-Amorphous Drug Formulations by the Addition of the Highly Water Soluble Amino Acid, Proline
title_sort improving co amorphous drug formulations by the addition of the highly water soluble amino acid proline
topic amino acid
co-amorphous
dissolution rate
DSC
FTIR
salt formation
solid state analysis
stability
XRPD
url http://www.mdpi.com/1999-4923/6/3/416
work_keys_str_mv AT katrinetarpjensen improvingcoamorphousdrugformulationsbytheadditionofthehighlywatersolubleaminoacidproline
AT korbinianlobmann improvingcoamorphousdrugformulationsbytheadditionofthehighlywatersolubleaminoacidproline
AT thomasrades improvingcoamorphousdrugformulationsbytheadditionofthehighlywatersolubleaminoacidproline
AT holgergrohganz improvingcoamorphousdrugformulationsbytheadditionofthehighlywatersolubleaminoacidproline